chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure, Speech disorder, Tremor
Clinical narrative: I've been having involuntary muscle jerks in my extremities. They are noticeable. Muscle shaking in my inner thighs, unsteady walking and pointer finger shaking. Convulsive-like jerking that wakes me up. Horrible cognitive problems, word recall, spelling and forgetfulness. The most terrible and shocking thing is not remembering how to pronounce simple words like 'smooth.' I eventually pronounce it, but it is so scary when it happens. This started off as annoyances I thought would go away, but they are getting worse. The muscle shaking is daily now, mostly when I'm lying down. The cognitive spelling and word recall issues also every day.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Chest pain, Computerised tomogram coronary artery abnormal, Constipation, Fall
Clinical narrative: He got his vaccine, got it at 11:00 AM at pharmacy, came home and worked around the house, took care of the horse and came in the house about 7:00 PM, and wasn't in the house 15 minutes and started shaking violently with tremors.  Tried to make it stop and his muscles were jerking all of the place.  He then got real thirsty and would open a bottle of water and opened it and could not drink it due to the tremors, was slopping it on the floor, and unable to do so.  Went up the stairs and fell down twice trying to get to the bed, and got in the bed.  The shaking stopped about an hour later, his temp was 104.3.  He did not eat or drink anything and then went to sleep.  In the morning it was 104.1, and it took 4 days to get down below 100.  He was not able to do anything for days, muscle pains, and abnormal bodily functions, and now has constipation and it is still not right.     He is having chest pains, muscle soreness and bowel movement issues (constipation).  He has frequency of urination now.  He saw his PCP and is going to see a cardiologist next week.  Had a calcium score done after this and it was 2842 was his level.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Feeding disorder, Hypophagia, Loss of personal independence in daily activities, Mobility decreased, Muscle contracture
Clinical narrative: He got his vaccine, got it at 11:00 AM at pharmacy, came home and worked around the house, took care of the horse and came in the house about 7:00 PM, and wasn't in the house 15 minutes and started shaking violently with tremors.  Tried to make it stop and his muscles were jerking all of the place.  He then got real thirsty and would open a bottle of water and opened it and could not drink it due to the tremors, was slopping it on the floor, and unable to do so.  Went up the stairs and fell down twice trying to get to the bed, and got in the bed.  The shaking stopped about an hour later, his temp was 104.3.  He did not eat or drink anything and then went to sleep.  In the morning it was 104.1, and it took 4 days to get down below 100.  He was not able to do anything for days, muscle pains, and abnormal bodily functions, and now has constipation and it is still not right.     He is having chest pains, muscle soreness and bowel movement issues (constipation).  He has frequency of urination now.  He saw his PCP and is going to see a cardiologist next week.  Had a calcium score done after this and it was 2842 was his level.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pollakiuria, Thirst, Tremor
Clinical narrative: He got his vaccine, got it at 11:00 AM at pharmacy, came home and worked around the house, took care of the horse and came in the house about 7:00 PM, and wasn't in the house 15 minutes and started shaking violently with tremors.  Tried to make it stop and his muscles were jerking all of the place.  He then got real thirsty and would open a bottle of water and opened it and could not drink it due to the tremors, was slopping it on the floor, and unable to do so.  Went up the stairs and fell down twice trying to get to the bed, and got in the bed.  The shaking stopped about an hour later, his temp was 104.3.  He did not eat or drink anything and then went to sleep.  In the morning it was 104.1, and it took 4 days to get down below 100.  He was not able to do anything for days, muscle pains, and abnormal bodily functions, and now has constipation and it is still not right.     He is having chest pains, muscle soreness and bowel movement issues (constipation).  He has frequency of urination now.  He saw his PCP and is going to see a cardiologist next week.  Had a calcium score done after this and it was 2842 was his level.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Foetal heart rate abnormal, Ultrasound scan abnormal
Clinical narrative: Healthy fetus until 9 days after vaccine.  The fetus became non-viable without a heart beat at 11W 0D.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Lymphadenopathy, Swelling, Ultrasound Doppler normal
Clinical narrative: On the next day of a booster shot, she developed swelling and local pain in left upper arm where she received the shot. Significant swelling in left upper arm spread to the upper chest (especially in the area around left clavicle). She also developed swelling and pain in axillary lymph node.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Cardiac failure, Cardiomyopathy, Catheterisation cardiac, Echocardiogram
Clinical narrative: Takotsubo cardiomyopathy, heart failure, arrythymia, sudden  death
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial necrosis marker, Stress cardiomyopathy, Sudden death
Clinical narrative: Takotsubo cardiomyopathy, heart failure, arrythymia, sudden  death
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Chills, Cough
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/27/21 (ER8729) Pfizer Dose 2 5/19/21 (EW0168) COVID Positive 9/16/21  9/22/21: Patient is a 58-year-old male who presented to an outside area emergency room with a roughly 1 week history of increasing fever, chills or night sweats as well as increasing shortness of breath, dyspnea and cough.  There is a recent history of being exposed to COVID via his mother.  The patient takes care of his mother on a regular basis who was known to recently have COVID.  Patient believes his exposure was roughly 7-10 days ago and he started to experience symptoms this past Wednesday and tested positive subsequently on Thursday.  Patient did also receive the immunoglobulin infusion on Monday which he states did help some for about 1 or 2 days after which time he started to feel ill again.  Patient did receive the Pfizer vaccine and did receive both injections.  At home the patient has felt febrile with some vague complaints of malaise, fatigue and weakness with body aches.  There has been increasing shortness of breath and dyspnea as well as an increasing cough.  No chest pain symptoms have been noted.  No recent changes to his medications.  The patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records have been personally reviewed.  Case was also discussed directly with the emergency room provider.  9/25/21: Patient was admitted on September 22, 2021 for evaluation COVID pneumonia.  Patient's COVID pneumonia was managed by antibiotics, remdesivir, Decadron.  Patient was requiring oxygen supplementation throughout most of the hospitalization.  Patient's hospital course was complicated due to the persistent oxygen supplementation.  Patient received a total of 4 days of antibiotics, 4 days of remdesivir, 4 days of Decadron.  A walk test for determination of home oxygen was conducted and determined that the patient did not need any oxygen for home.  Patient will need to complete a 5 day course of Levaquin after discharge.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Exposure to SARS-CoV-2, Fatigue, Immunoglobulin therapy, Inappropriate schedule of product administration
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/27/21 (ER8729) Pfizer Dose 2 5/19/21 (EW0168) COVID Positive 9/16/21  9/22/21: Patient is a 58-year-old male who presented to an outside area emergency room with a roughly 1 week history of increasing fever, chills or night sweats as well as increasing shortness of breath, dyspnea and cough.  There is a recent history of being exposed to COVID via his mother.  The patient takes care of his mother on a regular basis who was known to recently have COVID.  Patient believes his exposure was roughly 7-10 days ago and he started to experience symptoms this past Wednesday and tested positive subsequently on Thursday.  Patient did also receive the immunoglobulin infusion on Monday which he states did help some for about 1 or 2 days after which time he started to feel ill again.  Patient did receive the Pfizer vaccine and did receive both injections.  At home the patient has felt febrile with some vague complaints of malaise, fatigue and weakness with body aches.  There has been increasing shortness of breath and dyspnea as well as an increasing cough.  No chest pain symptoms have been noted.  No recent changes to his medications.  The patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records have been personally reviewed.  Case was also discussed directly with the emergency room provider.  9/25/21: Patient was admitted on September 22, 2021 for evaluation COVID pneumonia.  Patient's COVID pneumonia was managed by antibiotics, remdesivir, Decadron.  Patient was requiring oxygen supplementation throughout most of the hospitalization.  Patient's hospital course was complicated due to the persistent oxygen supplementation.  Patient received a total of 4 days of antibiotics, 4 days of remdesivir, 4 days of Decadron.  A walk test for determination of home oxygen was conducted and determined that the patient did not need any oxygen for home.  Patient will need to complete a 5 day course of Levaquin after discharge.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Night sweats, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/27/21 (ER8729) Pfizer Dose 2 5/19/21 (EW0168) COVID Positive 9/16/21  9/22/21: Patient is a 58-year-old male who presented to an outside area emergency room with a roughly 1 week history of increasing fever, chills or night sweats as well as increasing shortness of breath, dyspnea and cough.  There is a recent history of being exposed to COVID via his mother.  The patient takes care of his mother on a regular basis who was known to recently have COVID.  Patient believes his exposure was roughly 7-10 days ago and he started to experience symptoms this past Wednesday and tested positive subsequently on Thursday.  Patient did also receive the immunoglobulin infusion on Monday which he states did help some for about 1 or 2 days after which time he started to feel ill again.  Patient did receive the Pfizer vaccine and did receive both injections.  At home the patient has felt febrile with some vague complaints of malaise, fatigue and weakness with body aches.  There has been increasing shortness of breath and dyspnea as well as an increasing cough.  No chest pain symptoms have been noted.  No recent changes to his medications.  The patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records have been personally reviewed.  Case was also discussed directly with the emergency room provider.  9/25/21: Patient was admitted on September 22, 2021 for evaluation COVID pneumonia.  Patient's COVID pneumonia was managed by antibiotics, remdesivir, Decadron.  Patient was requiring oxygen supplementation throughout most of the hospitalization.  Patient's hospital course was complicated due to the persistent oxygen supplementation.  Patient received a total of 4 days of antibiotics, 4 days of remdesivir, 4 days of Decadron.  A walk test for determination of home oxygen was conducted and determined that the patient did not need any oxygen for home.  Patient will need to complete a 5 day course of Levaquin after discharge.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, Walking distance test normal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/27/21 (ER8729) Pfizer Dose 2 5/19/21 (EW0168) COVID Positive 9/16/21  9/22/21: Patient is a 58-year-old male who presented to an outside area emergency room with a roughly 1 week history of increasing fever, chills or night sweats as well as increasing shortness of breath, dyspnea and cough.  There is a recent history of being exposed to COVID via his mother.  The patient takes care of his mother on a regular basis who was known to recently have COVID.  Patient believes his exposure was roughly 7-10 days ago and he started to experience symptoms this past Wednesday and tested positive subsequently on Thursday.  Patient did also receive the immunoglobulin infusion on Monday which he states did help some for about 1 or 2 days after which time he started to feel ill again.  Patient did receive the Pfizer vaccine and did receive both injections.  At home the patient has felt febrile with some vague complaints of malaise, fatigue and weakness with body aches.  There has been increasing shortness of breath and dyspnea as well as an increasing cough.  No chest pain symptoms have been noted.  No recent changes to his medications.  The patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records have been personally reviewed.  Case was also discussed directly with the emergency room provider.  9/25/21: Patient was admitted on September 22, 2021 for evaluation COVID pneumonia.  Patient's COVID pneumonia was managed by antibiotics, remdesivir, Decadron.  Patient was requiring oxygen supplementation throughout most of the hospitalization.  Patient's hospital course was complicated due to the persistent oxygen supplementation.  Patient received a total of 4 days of antibiotics, 4 days of remdesivir, 4 days of Decadron.  A walk test for determination of home oxygen was conducted and determined that the patient did not need any oxygen for home.  Patient will need to complete a 5 day course of Levaquin after discharge.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Biopsy kidney abnormal, Condition aggravated, Creatinine urine increased, Nephrotic syndrome
Clinical narrative: Nephrotic syndrome with AKI. Kidney biopsy showed interstitial nephritis and podocyte foot process effacement. He was treated with pulse steroids and plasmapheresis with improvement.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Plasmapheresis, Protein urine, Tubulointerstitial nephritis
Clinical narrative: Nephrotic syndrome with AKI. Kidney biopsy showed interstitial nephritis and podocyte foot process effacement. He was treated with pulse steroids and plasmapheresis with improvement.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Hypoaesthesia, Tremor
Clinical narrative: Shaky and cold. Stable vitals 120/80. Numbness in her hands and shivering. Ambulance called at 11:35 am for evaluation. Vitals taken by emergency team. Patient released in her own private vehicle with husband as the driver.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia, Asthenia, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/8/21 (EN6203) COVID Positive 9/13/21  9/23/21: The patient was diagnosed with COVID-19 infection more than a week, referred to our hospital due to generalized weakness with episodes of fever and chills and episodes of dry cough with shortness of breath, decline orthopnea or chest pain or productive cough or nausea or vomiting or diarrhea. At emergency, she was mildly dyspneic and hypoxic 86% on room air required 2 L of oxygen. Her labs show CKD, stable anemia.  9/27/21: The patient presented to the hospital from assisting living facility complaining from worsen generalized weakness with cough, she was dyspneic and hypoxic requiring 3-4 L of oxygen initially at the ED, had wheezing and crepitation her chest exam, chest x-ray unremarkable for acute anomalies, her labs show moderate stable anemia, her CMP unremarkable, she was diagnosed with moderate COVID-19 pneumonia and she was started on dexamethasone IV with vitamins, initially had worsen renal function/AKI on CKD require IV fluid then her renal function improved and the patient started on Remdesivir with improvement in her symptoms.  We have been able to wean her of oxygen and clinically improved.  She had episodes of severe diarrhea require dedication management system and her C diff is negative.  Patient tolerated her diet and improved clinically.  Discussed with the patient, will discharge to her assisting living facility with VNA.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chills, Chronic kidney disease, Clostridium test negative, Cough
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/8/21 (EN6203) COVID Positive 9/13/21  9/23/21: The patient was diagnosed with COVID-19 infection more than a week, referred to our hospital due to generalized weakness with episodes of fever and chills and episodes of dry cough with shortness of breath, decline orthopnea or chest pain or productive cough or nausea or vomiting or diarrhea. At emergency, she was mildly dyspneic and hypoxic 86% on room air required 2 L of oxygen. Her labs show CKD, stable anemia.  9/27/21: The patient presented to the hospital from assisting living facility complaining from worsen generalized weakness with cough, she was dyspneic and hypoxic requiring 3-4 L of oxygen initially at the ED, had wheezing and crepitation her chest exam, chest x-ray unremarkable for acute anomalies, her labs show moderate stable anemia, her CMP unremarkable, she was diagnosed with moderate COVID-19 pneumonia and she was started on dexamethasone IV with vitamins, initially had worsen renal function/AKI on CKD require IV fluid then her renal function improved and the patient started on Remdesivir with improvement in her symptoms.  We have been able to wean her of oxygen and clinically improved.  She had episodes of severe diarrhea require dedication management system and her C diff is negative.  Patient tolerated her diet and improved clinically.  Discussed with the patient, will discharge to her assisting living facility with VNA.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Crepitations, Diarrhoea, Dyspnoea, Hypoxia, Inappropriate schedule of product administration
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/8/21 (EN6203) COVID Positive 9/13/21  9/23/21: The patient was diagnosed with COVID-19 infection more than a week, referred to our hospital due to generalized weakness with episodes of fever and chills and episodes of dry cough with shortness of breath, decline orthopnea or chest pain or productive cough or nausea or vomiting or diarrhea. At emergency, she was mildly dyspneic and hypoxic 86% on room air required 2 L of oxygen. Her labs show CKD, stable anemia.  9/27/21: The patient presented to the hospital from assisting living facility complaining from worsen generalized weakness with cough, she was dyspneic and hypoxic requiring 3-4 L of oxygen initially at the ED, had wheezing and crepitation her chest exam, chest x-ray unremarkable for acute anomalies, her labs show moderate stable anemia, her CMP unremarkable, she was diagnosed with moderate COVID-19 pneumonia and she was started on dexamethasone IV with vitamins, initially had worsen renal function/AKI on CKD require IV fluid then her renal function improved and the patient started on Remdesivir with improvement in her symptoms.  We have been able to wean her of oxygen and clinically improved.  She had episodes of severe diarrhea require dedication management system and her C diff is negative.  Patient tolerated her diet and improved clinically.  Discussed with the patient, will discharge to her assisting living facility with VNA.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Metabolic function test normal, Pyrexia, Renal impairment, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/8/21 (EN6203) COVID Positive 9/13/21  9/23/21: The patient was diagnosed with COVID-19 infection more than a week, referred to our hospital due to generalized weakness with episodes of fever and chills and episodes of dry cough with shortness of breath, decline orthopnea or chest pain or productive cough or nausea or vomiting or diarrhea. At emergency, she was mildly dyspneic and hypoxic 86% on room air required 2 L of oxygen. Her labs show CKD, stable anemia.  9/27/21: The patient presented to the hospital from assisting living facility complaining from worsen generalized weakness with cough, she was dyspneic and hypoxic requiring 3-4 L of oxygen initially at the ED, had wheezing and crepitation her chest exam, chest x-ray unremarkable for acute anomalies, her labs show moderate stable anemia, her CMP unremarkable, she was diagnosed with moderate COVID-19 pneumonia and she was started on dexamethasone IV with vitamins, initially had worsen renal function/AKI on CKD require IV fluid then her renal function improved and the patient started on Remdesivir with improvement in her symptoms.  We have been able to wean her of oxygen and clinically improved.  She had episodes of severe diarrhea require dedication management system and her C diff is negative.  Patient tolerated her diet and improved clinically.  Discussed with the patient, will discharge to her assisting living facility with VNA.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/8/21 (EN6203) COVID Positive 9/13/21  9/23/21: The patient was diagnosed with COVID-19 infection more than a week, referred to our hospital due to generalized weakness with episodes of fever and chills and episodes of dry cough with shortness of breath, decline orthopnea or chest pain or productive cough or nausea or vomiting or diarrhea. At emergency, she was mildly dyspneic and hypoxic 86% on room air required 2 L of oxygen. Her labs show CKD, stable anemia.  9/27/21: The patient presented to the hospital from assisting living facility complaining from worsen generalized weakness with cough, she was dyspneic and hypoxic requiring 3-4 L of oxygen initially at the ED, had wheezing and crepitation her chest exam, chest x-ray unremarkable for acute anomalies, her labs show moderate stable anemia, her CMP unremarkable, she was diagnosed with moderate COVID-19 pneumonia and she was started on dexamethasone IV with vitamins, initially had worsen renal function/AKI on CKD require IV fluid then her renal function improved and the patient started on Remdesivir with improvement in her symptoms.  We have been able to wean her of oxygen and clinically improved.  She had episodes of severe diarrhea require dedication management system and her C diff is negative.  Patient tolerated her diet and improved clinically.  Discussed with the patient, will discharge to her assisting living facility with VNA.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administer after the 31 day refrigeration date but before the 45 day excursion time.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Fatigue, Heart rate decreased, Hypertension
Clinical narrative: Pain in chest, abnormal breathing heartbeat, low /high blood pressure, fatigue, anxiety, nausea, and fever.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Respiration abnormal
Clinical narrative: Pain in chest, abnormal breathing heartbeat, low /high blood pressure, fatigue, anxiety, nausea, and fever.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: Patient lost consciousness approximately 3 mins after receiving vaccine. Patient quickly returned to alert and oriented.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Spontaneous urticaria sparing only soles of feet lasting 7 days. resistant to antihistamines and topical steroid. treated with oral methylprednisolone and depomedrol injection.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient mistakenly given 4th dose which is currently not recommended
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient given 0.2ml dose of undiluted vaccine. No symptoms or side effects noted.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Ultrasound scan
Clinical narrative: Two months with severe pain in the left breast.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Pruritus
Clinical narrative: Patient reported generalized itching and difficulty swallowing spit. No rash noted. No difficulty breathing. Patient observed by emergency team.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Headache, Sensory loss
Clinical narrative: Headache, brain fog, lightheaded, lost of sensitivity on right leg and fatigue.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error
Clinical narrative: Patient given 0.2ml dose of undiluted vaccine. no symptoms or side effects noted.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: vaccine dose given with diluting prior to use. no adverse reactions noted at this time.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt was given Moderna vaccine but was 17 at the time of injection. No adverse reactions. Pt tolerated well.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring normal, Chest X-ray normal, Electrocardiogram normal, Hypertension, Palpitations
Clinical narrative: I had heart palpitation and my blood pressure was high, I was prescribed low dose of BP medication to maintain a decent Blood Pressure.
Age: 30.0
Sex: F
Vaccine: FLUC4
Symptoms: Erythema, Pruritus
Clinical narrative: 2:02 pm Patient received Influenza vaccine 2:20 pm Patient complaining of itching and redness to right arm. 2:30 pm Patient assessed and seen in clinic by doctor. Diphenhydramine 50 mg/ml injection  0.5ml  IM x one dose today and Benadryl  25 mg one capsule every six hours as needed for itching prescribed. 3:38 pm  Diphenhydramine 50 mg/ml injection  0.5ml  IM x one dose given and patient observed for 15 minutes.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient given Moderna vaccine at age 17 during the time of injection. No adverse reactions. Patient tolerated well.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Symptom onset 12/28/2021.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: UNDILUTED VACCINE DOSE (20MCG) GIVEN TO PATIENT, INSTEAD OF 10MCG 5-11 AGE DOSE
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood albumin decreased, Blood bilirubin increased, Blood calcium decreased, Blood creatinine decreased
Clinical narrative: COVID Vaccine Breakthrough  Pfizer Dose 1 3/8/21 (EN6203) Pfizer Dose 2 4/9/21 (ER8737) COVID Positive 9/30/21 Presented to and discharged from ED 9/30/21  10/1/21: Patient is an 84-year-old male who presents to the ED today with complaints of generalized weakness that began about 5 days ago.  The patient  tested positive for COVID-19  yesterday.   the patient is vaccinated for COVID-19.  Patient's accompanying symptoms include decreased appetite, productive cough, mild shortness of breath.  Patient denies any fever, chills, body aches, nausea /vomiting, diarrhea.  Patient also has sustained falls over the last couple of days with no injuries except for abrasions on his bilateral shins.  Patient is currently taking PO Levaquin for UTI.  Patient has a past medical history significant for atrial fibrillation, BPH, CAD, hypertension, OSA, Parkinson's disease, neuropathy.   Upon arrival to ED patient's temperature is 98.1, heart rate 100, respirations 24, pulse ox 96% on room air, blood pressure 124/60. Patient had a chest x-ray completed yesterday that shows stable cardiomegaly without acute cardiopulmonary process.   patient had laboratory studies drawn yesterday which reveals WBC 4.21,  INR 1.8, CRP 4.10, glucose 157, creatinine 0.52, total bili 1.5, albumin 3.2, calcium 8.0, lactic acid 2.8, proBNP 794.   Patient was seen and examined at the bedside on the medical pulmonary unit.  The patient is currently resting, in no acute distress.  Patient continues to complain of significant weakness, fatigue, body aches.  Patient denies any chest pain, shortness of breath, nausea/vomiting. Patient states his son was taking care of him, however, he tested positive for COVID-19 today making it difficult for him to take care of him with his excessive weakness at this time.  10/5/21: Patient is an 84-year-old male who was admitted on 10/01/2021 with chief complaint of generalized weakness. Patient was found to be COVID-19 positive on 09/30/2021. He was vaccinated.  He did not require supplemental oxygen, but his family was unable to take care of him at home due to the amount of weakness and fatigue he was experiencing. He was continued on his previous home medicines and received antibiotics as he was recently diagnosed with the urinary tract infection in the outpatient setting.  On 10/05/2021, the patient was discharged to a skilled nursing facility can not to continue his previous home medication regimen.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood lactic acid, C-reactive protein increased, COVID-19, Cardiomegaly
Clinical narrative: COVID Vaccine Breakthrough  Pfizer Dose 1 3/8/21 (EN6203) Pfizer Dose 2 4/9/21 (ER8737) COVID Positive 9/30/21 Presented to and discharged from ED 9/30/21  10/1/21: Patient is an 84-year-old male who presents to the ED today with complaints of generalized weakness that began about 5 days ago.  The patient  tested positive for COVID-19  yesterday.   the patient is vaccinated for COVID-19.  Patient's accompanying symptoms include decreased appetite, productive cough, mild shortness of breath.  Patient denies any fever, chills, body aches, nausea /vomiting, diarrhea.  Patient also has sustained falls over the last couple of days with no injuries except for abrasions on his bilateral shins.  Patient is currently taking PO Levaquin for UTI.  Patient has a past medical history significant for atrial fibrillation, BPH, CAD, hypertension, OSA, Parkinson's disease, neuropathy.   Upon arrival to ED patient's temperature is 98.1, heart rate 100, respirations 24, pulse ox 96% on room air, blood pressure 124/60. Patient had a chest x-ray completed yesterday that shows stable cardiomegaly without acute cardiopulmonary process.   patient had laboratory studies drawn yesterday which reveals WBC 4.21,  INR 1.8, CRP 4.10, glucose 157, creatinine 0.52, total bili 1.5, albumin 3.2, calcium 8.0, lactic acid 2.8, proBNP 794.   Patient was seen and examined at the bedside on the medical pulmonary unit.  The patient is currently resting, in no acute distress.  Patient continues to complain of significant weakness, fatigue, body aches.  Patient denies any chest pain, shortness of breath, nausea/vomiting. Patient states his son was taking care of him, however, he tested positive for COVID-19 today making it difficult for him to take care of him with his excessive weakness at this time.  10/5/21: Patient is an 84-year-old male who was admitted on 10/01/2021 with chief complaint of generalized weakness. Patient was found to be COVID-19 positive on 09/30/2021. He was vaccinated.  He did not require supplemental oxygen, but his family was unable to take care of him at home due to the amount of weakness and fatigue he was experiencing. He was continued on his previous home medicines and received antibiotics as he was recently diagnosed with the urinary tract infection in the outpatient setting.  On 10/05/2021, the patient was discharged to a skilled nursing facility can not to continue his previous home medication regimen.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Decreased appetite, Dyspnoea, Fall, Fatigue
Clinical narrative: COVID Vaccine Breakthrough  Pfizer Dose 1 3/8/21 (EN6203) Pfizer Dose 2 4/9/21 (ER8737) COVID Positive 9/30/21 Presented to and discharged from ED 9/30/21  10/1/21: Patient is an 84-year-old male who presents to the ED today with complaints of generalized weakness that began about 5 days ago.  The patient  tested positive for COVID-19  yesterday.   the patient is vaccinated for COVID-19.  Patient's accompanying symptoms include decreased appetite, productive cough, mild shortness of breath.  Patient denies any fever, chills, body aches, nausea /vomiting, diarrhea.  Patient also has sustained falls over the last couple of days with no injuries except for abrasions on his bilateral shins.  Patient is currently taking PO Levaquin for UTI.  Patient has a past medical history significant for atrial fibrillation, BPH, CAD, hypertension, OSA, Parkinson's disease, neuropathy.   Upon arrival to ED patient's temperature is 98.1, heart rate 100, respirations 24, pulse ox 96% on room air, blood pressure 124/60. Patient had a chest x-ray completed yesterday that shows stable cardiomegaly without acute cardiopulmonary process.   patient had laboratory studies drawn yesterday which reveals WBC 4.21,  INR 1.8, CRP 4.10, glucose 157, creatinine 0.52, total bili 1.5, albumin 3.2, calcium 8.0, lactic acid 2.8, proBNP 794.   Patient was seen and examined at the bedside on the medical pulmonary unit.  The patient is currently resting, in no acute distress.  Patient continues to complain of significant weakness, fatigue, body aches.  Patient denies any chest pain, shortness of breath, nausea/vomiting. Patient states his son was taking care of him, however, he tested positive for COVID-19 today making it difficult for him to take care of him with his excessive weakness at this time.  10/5/21: Patient is an 84-year-old male who was admitted on 10/01/2021 with chief complaint of generalized weakness. Patient was found to be COVID-19 positive on 09/30/2021. He was vaccinated.  He did not require supplemental oxygen, but his family was unable to take care of him at home due to the amount of weakness and fatigue he was experiencing. He was continued on his previous home medicines and received antibiotics as he was recently diagnosed with the urinary tract infection in the outpatient setting.  On 10/05/2021, the patient was discharged to a skilled nursing facility can not to continue his previous home medication regimen.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, International normalised ratio decreased, Pain, Productive cough, Prohormone brain natriuretic peptide increased
Clinical narrative: COVID Vaccine Breakthrough  Pfizer Dose 1 3/8/21 (EN6203) Pfizer Dose 2 4/9/21 (ER8737) COVID Positive 9/30/21 Presented to and discharged from ED 9/30/21  10/1/21: Patient is an 84-year-old male who presents to the ED today with complaints of generalized weakness that began about 5 days ago.  The patient  tested positive for COVID-19  yesterday.   the patient is vaccinated for COVID-19.  Patient's accompanying symptoms include decreased appetite, productive cough, mild shortness of breath.  Patient denies any fever, chills, body aches, nausea /vomiting, diarrhea.  Patient also has sustained falls over the last couple of days with no injuries except for abrasions on his bilateral shins.  Patient is currently taking PO Levaquin for UTI.  Patient has a past medical history significant for atrial fibrillation, BPH, CAD, hypertension, OSA, Parkinson's disease, neuropathy.   Upon arrival to ED patient's temperature is 98.1, heart rate 100, respirations 24, pulse ox 96% on room air, blood pressure 124/60. Patient had a chest x-ray completed yesterday that shows stable cardiomegaly without acute cardiopulmonary process.   patient had laboratory studies drawn yesterday which reveals WBC 4.21,  INR 1.8, CRP 4.10, glucose 157, creatinine 0.52, total bili 1.5, albumin 3.2, calcium 8.0, lactic acid 2.8, proBNP 794.   Patient was seen and examined at the bedside on the medical pulmonary unit.  The patient is currently resting, in no acute distress.  Patient continues to complain of significant weakness, fatigue, body aches.  Patient denies any chest pain, shortness of breath, nausea/vomiting. Patient states his son was taking care of him, however, he tested positive for COVID-19 today making it difficult for him to take care of him with his excessive weakness at this time.  10/5/21: Patient is an 84-year-old male who was admitted on 10/01/2021 with chief complaint of generalized weakness. Patient was found to be COVID-19 positive on 09/30/2021. He was vaccinated.  He did not require supplemental oxygen, but his family was unable to take care of him at home due to the amount of weakness and fatigue he was experiencing. He was continued on his previous home medicines and received antibiotics as he was recently diagnosed with the urinary tract infection in the outpatient setting.  On 10/05/2021, the patient was discharged to a skilled nursing facility can not to continue his previous home medication regimen.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Skin abrasion, Urinary tract infection, Vaccine breakthrough infection, White blood cell count decreased
Clinical narrative: COVID Vaccine Breakthrough  Pfizer Dose 1 3/8/21 (EN6203) Pfizer Dose 2 4/9/21 (ER8737) COVID Positive 9/30/21 Presented to and discharged from ED 9/30/21  10/1/21: Patient is an 84-year-old male who presents to the ED today with complaints of generalized weakness that began about 5 days ago.  The patient  tested positive for COVID-19  yesterday.   the patient is vaccinated for COVID-19.  Patient's accompanying symptoms include decreased appetite, productive cough, mild shortness of breath.  Patient denies any fever, chills, body aches, nausea /vomiting, diarrhea.  Patient also has sustained falls over the last couple of days with no injuries except for abrasions on his bilateral shins.  Patient is currently taking PO Levaquin for UTI.  Patient has a past medical history significant for atrial fibrillation, BPH, CAD, hypertension, OSA, Parkinson's disease, neuropathy.   Upon arrival to ED patient's temperature is 98.1, heart rate 100, respirations 24, pulse ox 96% on room air, blood pressure 124/60. Patient had a chest x-ray completed yesterday that shows stable cardiomegaly without acute cardiopulmonary process.   patient had laboratory studies drawn yesterday which reveals WBC 4.21,  INR 1.8, CRP 4.10, glucose 157, creatinine 0.52, total bili 1.5, albumin 3.2, calcium 8.0, lactic acid 2.8, proBNP 794.   Patient was seen and examined at the bedside on the medical pulmonary unit.  The patient is currently resting, in no acute distress.  Patient continues to complain of significant weakness, fatigue, body aches.  Patient denies any chest pain, shortness of breath, nausea/vomiting. Patient states his son was taking care of him, however, he tested positive for COVID-19 today making it difficult for him to take care of him with his excessive weakness at this time.  10/5/21: Patient is an 84-year-old male who was admitted on 10/01/2021 with chief complaint of generalized weakness. Patient was found to be COVID-19 positive on 09/30/2021. He was vaccinated.  He did not require supplemental oxygen, but his family was unable to take care of him at home due to the amount of weakness and fatigue he was experiencing. He was continued on his previous home medicines and received antibiotics as he was recently diagnosed with the urinary tract infection in the outpatient setting.  On 10/05/2021, the patient was discharged to a skilled nursing facility can not to continue his previous home medication regimen.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Inflammation, Mobility decreased, Polymyalgia rheumatica
Clinical narrative: I received the vaccine and then a week later could not role over in bed.  A visit to the doctor revealed an extreme inflammatory response, diagnosed as PMR.  Unknown as to whether the vaccine was the cause, the Rheumatologist treated accordingly with heavy rounds of prednisone.  My inflammation was brought back to normal by summer.  By September, I was in remission.  I decided to get the second vaccine.  I reacted the same way as I did to the first - confirming that there was a connection between the vaccine and the onset of PMR.    I am afraid to get the booster.  I am slowly working my way to normal inflammation once again.  I have been treated by a rheumatologist and have monthly blood work done to track my progress.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood magnesium, Cardiac ablation, Chest X-ray, Electrocardiogram, Full blood count
Clinical narrative: A month after my second vaccine I started having Sinus tachycardia. My cardiologist put me on Metoprolol. On 5/7/21 I went to the local Health ER with SVT's. I ended up having Adenosine (which stopped my heart). Normal sinus rhythm returned.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Metabolic function test, Sinus tachycardia, Supraventricular tachycardia, Troponin
Clinical narrative: A month after my second vaccine I started having Sinus tachycardia. My cardiologist put me on Metoprolol. On 5/7/21 I went to the local Health ER with SVT's. I ended up having Adenosine (which stopped my heart). Normal sinus rhythm returned.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Pt received the wrong Pfizer vaccination. Pt received the orange top instead of the purple top.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Extreme dizziness
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Injection site swelling, Neuropathy peripheral, Rash, Rash pruritic
Clinical narrative: Itchy rash appeared on neck, swelling at injection site and worsened neuropathy.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received vaccine on 1/15/2022 with a BUD date of 1/9/2022. No adverse event. Offered to be revaccinated per guidelines.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased, Blood bilirubin increased, Burning sensation
Clinical narrative: Pfizer COVID Vaccine EUA: Rash, Serum Sickness, Febrile Illness. Patient received Pfizer Vaccines on 12/22/2021 and 1/21/2022. Presented to ED 1/28/2022 with complaints of pain in palms and soles x24 hours, with burning sensation, and rash on palms, soles, and over bilateral knees. Febrile on presentation with AST = 106, ALT = 173, Alkaline Phosphatase ALP = 305, Total Bili = 2.2, CRP 14.9 (Increased to 25.4 on 1/31). C3 Complement = 168, C4 Complement = 13.4, WBC 14.8 on 1/29 and 21.3 on 1/31, Hepatitis panel negative, HIV negative, RSV negative, Respiratory viral panel all negative, syphilis negative, typhus negative, Neisseria and chlamydial negative. Symptoms resolved with steroids, discharged home hospital day 4 on steroids.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Chlamydia test negative, Complement factor C3, Complement factor C4 decreased, HIV test negative
Clinical narrative: Pfizer COVID Vaccine EUA: Rash, Serum Sickness, Febrile Illness. Patient received Pfizer Vaccines on 12/22/2021 and 1/21/2022. Presented to ED 1/28/2022 with complaints of pain in palms and soles x24 hours, with burning sensation, and rash on palms, soles, and over bilateral knees. Febrile on presentation with AST = 106, ALT = 173, Alkaline Phosphatase ALP = 305, Total Bili = 2.2, CRP 14.9 (Increased to 25.4 on 1/31). C3 Complement = 168, C4 Complement = 13.4, WBC 14.8 on 1/29 and 21.3 on 1/31, Hepatitis panel negative, HIV negative, RSV negative, Respiratory viral panel all negative, syphilis negative, typhus negative, Neisseria and chlamydial negative. Symptoms resolved with steroids, discharged home hospital day 4 on steroids.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatitis viral test negative, Illness, Inappropriate schedule of product administration, Laboratory test normal, Neisseria test negative
Clinical narrative: Pfizer COVID Vaccine EUA: Rash, Serum Sickness, Febrile Illness. Patient received Pfizer Vaccines on 12/22/2021 and 1/21/2022. Presented to ED 1/28/2022 with complaints of pain in palms and soles x24 hours, with burning sensation, and rash on palms, soles, and over bilateral knees. Febrile on presentation with AST = 106, ALT = 173, Alkaline Phosphatase ALP = 305, Total Bili = 2.2, CRP 14.9 (Increased to 25.4 on 1/31). C3 Complement = 168, C4 Complement = 13.4, WBC 14.8 on 1/29 and 21.3 on 1/31, Hepatitis panel negative, HIV negative, RSV negative, Respiratory viral panel all negative, syphilis negative, typhus negative, Neisseria and chlamydial negative. Symptoms resolved with steroids, discharged home hospital day 4 on steroids.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rash, Respiratory syncytial virus test negative, Respiratory viral panel
Clinical narrative: Pfizer COVID Vaccine EUA: Rash, Serum Sickness, Febrile Illness. Patient received Pfizer Vaccines on 12/22/2021 and 1/21/2022. Presented to ED 1/28/2022 with complaints of pain in palms and soles x24 hours, with burning sensation, and rash on palms, soles, and over bilateral knees. Febrile on presentation with AST = 106, ALT = 173, Alkaline Phosphatase ALP = 305, Total Bili = 2.2, CRP 14.9 (Increased to 25.4 on 1/31). C3 Complement = 168, C4 Complement = 13.4, WBC 14.8 on 1/29 and 21.3 on 1/31, Hepatitis panel negative, HIV negative, RSV negative, Respiratory viral panel all negative, syphilis negative, typhus negative, Neisseria and chlamydial negative. Symptoms resolved with steroids, discharged home hospital day 4 on steroids.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Serum sickness, Treponema test negative, White blood cell count increased
Clinical narrative: Pfizer COVID Vaccine EUA: Rash, Serum Sickness, Febrile Illness. Patient received Pfizer Vaccines on 12/22/2021 and 1/21/2022. Presented to ED 1/28/2022 with complaints of pain in palms and soles x24 hours, with burning sensation, and rash on palms, soles, and over bilateral knees. Febrile on presentation with AST = 106, ALT = 173, Alkaline Phosphatase ALP = 305, Total Bili = 2.2, CRP 14.9 (Increased to 25.4 on 1/31). C3 Complement = 168, C4 Complement = 13.4, WBC 14.8 on 1/29 and 21.3 on 1/31, Hepatitis panel negative, HIV negative, RSV negative, Respiratory viral panel all negative, syphilis negative, typhus negative, Neisseria and chlamydial negative. Symptoms resolved with steroids, discharged home hospital day 4 on steroids.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received a vaccine on 1/15/2022 with a BUD of 1/9/2022. No adverse reactions. Patient  offered revaccination per guidelines.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Bacterial vaginosis, COVID-19, Cough, Nasopharyngitis
Clinical narrative: After receiving the 2nd dose she had a sore arm. When she caught covid she had cold like symptoms. She had a very low fever, runny nose, and a little bit of a cough. She said her smell was a little off as well. During coivd she had a flare up of bacterial vaginosis. She was prescribed metronidazole for it.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: After receiving the 2nd dose she had a sore arm. When she caught covid she had cold like symptoms. She had a very low fever, runny nose, and a little bit of a cough. She said her smell was a little off as well. During coivd she had a flare up of bacterial vaginosis. She was prescribed metronidazole for it.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Pt received the wrong Pfizer vaccine. Pt received the orange top instead of the purple top.